These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8118700)
1. The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Lê AD; Poulos CX; Quan B; Chow S Brain Res; 1993 Dec; 630(1-2):330-2. PubMed ID: 8118700 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Stromberg MF; Casale M; Volpicelli L; Volpicelli JR; O'Brien CP Alcohol; 1998 May; 15(4):281-9. PubMed ID: 9590512 [TBL] [Abstract][Full Text] [Related]
3. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Ciccocioppo R; Martin-Fardon R; Weiss F Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696 [TBL] [Abstract][Full Text] [Related]
4. The effect of antagonists selective for mu- and delta-opioid receptor subtypes on alcohol consumption in C57BL/6 mice. Kim SG; Stromberg MF; Kim MJ; Volpicelli JR; Park JM Alcohol; 2000 Oct; 22(2):85-90. PubMed ID: 11113622 [TBL] [Abstract][Full Text] [Related]
5. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578 [TBL] [Abstract][Full Text] [Related]
6. The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake. van Rijn RM; Whistler JL Biol Psychiatry; 2009 Oct; 66(8):777-84. PubMed ID: 19576572 [TBL] [Abstract][Full Text] [Related]
7. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats. Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897 [TBL] [Abstract][Full Text] [Related]
8. Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin. Riley AL; Melton PM Pharmacol Biochem Behav; 1997; 57(1-2):57-62. PubMed ID: 9164554 [TBL] [Abstract][Full Text] [Related]
9. Opioidergic modulation of ethanol self-administration in the ventral pallidum. Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714 [TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular injection of mu- and delta-opiate receptor antagonists block 60 Hz magnetic field-induced decreases in cholinergic activity in the frontal cortex and hippocampus of the rat. Lai H; Carino M Bioelectromagnetics; 1998; 19(7):432-7. PubMed ID: 9771587 [TBL] [Abstract][Full Text] [Related]
16. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Arjune D; Standifer KM; Pasternak GW; Bodnar RJ Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340 [TBL] [Abstract][Full Text] [Related]
17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
18. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Williams KL; Woods JH Alcohol Clin Exp Res; 1998 Nov; 22(8):1634-9. PubMed ID: 9835275 [TBL] [Abstract][Full Text] [Related]
19. Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice. Middaugh LD; Kelley BM; Groseclose CH; Cuison ER Pharmacol Biochem Behav; 2000 Jan; 65(1):145-54. PubMed ID: 10638648 [TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm. Katsuura Y; Taha SA Neuroscience; 2014 Mar; 261():144-52. PubMed ID: 24342569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]